Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.

Steere B, Schmitz J, Powell N, Higgs R, Gottlieb K, Liu Y, Jia B, Tuttle JL, Sandborn WJ, Sands BE, D'Haens G, Reinisch W, Krishnan V

Open source

DOI: 10.14309/ctg.0000000000000578
Published: 2023 Jul 1
Container: Clinical and translational gastroenterology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.14309/ctg.0000000000000578,
  title = {Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.},
  author = {Steere B and Schmitz J and Powell N and Higgs R and Gottlieb K and Liu Y and Jia B and Tuttle JL and Sandborn WJ and Sands BE and D'Haens G and Reinisch W and Krishnan V},
  year = {2023},
  journal = {Clinical and translational gastroenterology},
  doi = {10.14309/ctg.0000000000000578},
  url = {https://doi.org/10.14309/ctg.0000000000000578}
}

RIS

TY  - JOUR
TI  - Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.
AU  - Steere B
AU  - Schmitz J
AU  - Powell N
AU  - Higgs R
AU  - Gottlieb K
AU  - Liu Y
AU  - Jia B
AU  - Tuttle JL
AU  - Sandborn WJ
AU  - Sands BE
AU  - D'Haens G
AU  - Reinisch W
AU  - Krishnan V
PY  - 2023
JO  - Clinical and translational gastroenterology
DO  - 10.14309/ctg.0000000000000578
UR  - https://doi.org/10.14309/ctg.0000000000000578
ER  -

APA

B, S., J, S., N, P., R, H., K, G., Y, L., B, J., JL, T., WJ, S., BE, S., G, D., W, R., & V, K. (2023). Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.. Clinical and translational gastroenterology. https://doi.org/10.14309/ctg.0000000000000578

Source records

pubmed · retrieved 2026-09-26T18:28:50.992Z